NanoViricides, Inc. (NYSEMKT:NNVC) has filed its quarterly report with the Securities and Exchange Commission on Thursday, in a timely fashion. The submission can be downloaded from the SEC website. The Company estimates that it now has approximately $36.6M of current assets plus restricted cash in hand as of the date of filing. The Company estimates that this funding is sufficient to enable us to perform initial human clinical trials of our injectable FluCide™ drug candidate, as well as possibly to advance our DengueCide™ orphan drug candidate towards initial human clinical trials. The Company’s estimates are based on its current rate of expenditure and also on certain approximate estimates for clinical development of its drug candidate as gleaned from discussions with various contract research organizations. NanoViricides Inc (NYSEMKT:NNVC) weekly performance is -2.42%. On last trading day company shares ended up $3.22. Analysts mean target price for the company is $7.11. NanoViricides Inc (NYSEMKT:NNVC) distance from 50-day simple moving average (SMA50) is -6.00%.
Ryanair Holdings plc (ADR) (NASDAQ:RYAAY) announced that beginning October 30, 2014, travelers can now enjoy a new Cardiff route to/from Tenerife. According to the Company, the new weekly service route is expected to deliver over 15,000 customers per annum at Cardiff Airport – the Company’s 15th UK airport. The Company informed that in celebration of its new Cardiff flights, Ryanair is releasing seats for sale to Tenerife with prices starting from GBP39.99 for travel in November. Ryanair Holdings plc (ADR) (NASDAQ:RYAAY) shares advanced 7.26% in last trading session and ended the day on $54.68. Gross Margin is 30.50% and its return on assets is 5.90%. Ryanair Holdings plc (ADR) (NASDAQ:RYAAY) quarterly performance is -2.18%.
AngloGold Ashanti (NYSE:AU) posted a strong set of results, beating first-quarter production and cost guidance, as operating performance and cost initiatives continue to reposition the business. Adjusted headline earnings were $119m, or 29 US cents per share. First-quarter production of 1.06Moz at a total cash cost of $770/oz, was the strongest first quarter performance in four years, compared with guidance of 950,000oz to 1Moz at a total cash cost of $800/oz to $850/oz. AngloGold Ashanti’s all-in sustaining cost, which includes sustaining capital expenditure, as well as corporate and exploration costs, declined by 22% to $993/oz. The 17% rise in production year-on-year and 22% decline in costs were aided by the continued ramp-up of the two new, low-cost Kibali and Tropicana mines, together with ongoing efficiency improvements across the company. AngloGold Ashanti Limited (ADR) (NYSE:AU) shares moved up 0.83% in last trading session and was closed at $17.03, while trading in range of $16.89 – $17.72. AngloGold Ashanti Limited (ADR) (NYSE:AU) year to date (YTD) performance is 45.31%.
GameStop Corp. (NYSE:GME) a family of specialty retail brands that makes customers’ favorite technologies affordable and simple, is re-launching its U.S. PC digital distribution service, making it easier and more convenient than ever for customers to get access to the PC versions of the hottest video game titles around. GameStop Corp. (NYSE:GME) ended the last trading day at $36.98. Company weekly volatility is calculated as 3.22% and price to cash ratio as 7.90. GameStop Corp. (NYSE:GME) showed a positive weekly performance of 0.43%.
Liberum Capital reiterated their buy rating on shares of Royal Bank of Scotland Group plc (ADR) (NYSE:RBS) in a research note released on Friday morning. Royal Bank of Scotland Group plc (ADR) (NYSE:RBS) net profit margin is -50.80% and weekly performance is -1.36%. On last trading day company shares ended up $10.86. Analysts mean target price for the company is $866.05. Royal Bank of Scotland Group plc (ADR) (NYSE:RBS) distance from 50-day simple moving average (SMA50) is 4.26%.
Leave a Reply